Fox Factory Holding (FOXF) came out with quarterly earnings of $0.2 per share, beating the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.31 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +42.86%. A quarter ago, it was expected that this vehicle suspension maker would post earnings of $0.56 per share when it actually produced earnings of $0.23, delivering a surprise of -58.93%.Over the last four ...

NCR Atleos (NATL) came out with quarterly earnings of $1.49 per share, beating the Zacks Consensus Estimate of $1.32 per share. This compares to earnings of $1.11 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +12.88%. A quarter ago, it was expected that this provider of ATM services would post earnings of $1.01 per share when it actually produced earnings of $1.09, delivering a surprise of +7.92%.Over the last four quarters, ...

Natera (NTRA) came out with quarterly earnings of $0.35 per share, beating the Zacks Consensus Estimate of a loss of $0.46 per share. This compares to a loss of $0.41 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +175.43%. A quarter ago, it was expected that this genetic testing company would post a loss of $0.39 per share when it actually produced a loss of $0.64, delivering a surprise of -64.1%.Over the last four quarters, ...

OPKO Health (OPK) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to earnings of $0.01 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +39.39%. A quarter ago, it was expected that this holding company with investments in pharmaceutical and diagnostics companies would post a loss of $0.02 per share when it actually produced earnings of $0.03, delivering a s ...

Pembina Pipeline (PBA) came out with quarterly earnings of $0.56 per share, beating the Zacks Consensus Estimate of $0.5 per share. This compares to earnings of $0.66 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +12.74%. A quarter ago, it was expected that this oil and gas transportation and services company would post earnings of $0.45 per share when it actually produced earnings of $0.31, delivering a surprise of -31.11%. ...

securities you may be entitled to compensation without payment of any out of pocket fees or costs through a con...[Back to Newsroom]## Wish your news had this kind of reach?[Sign Up][Learn About Business Wire] Rosen Law Firm Urges Lakeland Industries, Inc. (NASDAQ: LAKE) Stockholders to Contact the Firm for Information About Their RightsFeb 26, 2026 7:46 PM Eastern Standard Time# Rosen Law Firm Urges Lakeland Industries, Inc. (NASDAQ: LAKE) Stockholders to Contact the Firm for Information About Their Rights ...

Twitter co-founder Jack Dorsey is axing more than 4,000 employees at his fintech company Block — slashing the workforce by nearly half in what he called a necessary shift toward ‘intelligence tools.’Dorsey sent a letter to shareholders saying the company, which owns Square, Cash App and Afterpay, will reduce 10,205 staff to just under 6,00. 3 Jack Dorsey’s Block, which owns Square and Cash App, is cutting 4,000 jobs, or 40% of its workforce. Bloomberg via Getty Images 3 The company said it expects to in ...

Twitter co-founder Jack Dorsey is axing more than 4,000 employees at his fintech company Block — slashing the workforce by nearly half in what he called a necessary shift toward ‘intelligence tools.’Dorsey sent a letter to shareholders saying the company, which owns Square, Cash App and Afterpay, will reduce 10,205 staff to just under 6,00. 3 Jack Dorsey’s Block, which owns Square and Cash App, is cutting 4,000 jobs, or 40% of its workforce. Bloomberg via Getty Images 3 The company said it expects to in ...

Brendan, a Pennsylvanian by birth:-Completed a Ph.D. at Stanford University in the field of organic synthesis (2009). -Worked for a major pharmaceutical company (Merck, 2009-2013).-Worked in biotech including start-ups (Theravance/Aspira) prior to securing employment at Caltech.-First employee and co-founder of 1200 Pharma as it spun out of Caltech garnering major investment (into the 8 figures).-Remains an avid investor, focused on market trends and especially biotechnology stocks.Analyst’s Disclosure: I/w ...

NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided financial results and an operational update for the period ended December 31, 2025 (H1 FY2026). FINANCIAL HIGHLIGHTS FOR H1 FY20261 Performance driven by successful commercial launch of Ryoncil® Total revenue of US$51.3 million (A$78.3 million),2 up from US$3.2 million.Successful U.S. commercial launch of Ryoncil® (remestemcel-L-rknd) ...